Garg Pushkal

EDGAR CIK 0001829252

Alnylam Pharmaceuticals, Inc. - ALNY

Officer
EVP Chief R&D
Direct Buys
0
$0
0 Shares
Direct Sells
10
($7.89) M
-20,767 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
03/05/2026
10b5-1
03/06/2026
Sell
-2,404 @ $323.96
($778,812) 18,693 (-11.39%) Direct
03/04/2026
03/06/2026
Sell
-2,309 @ $323.08
($745,984) 21,097 (-9.86%) Direct
03/03/2026
10b5-1
03/04/2026
Sell
-1,775 @ $319.74
($567,546) 23,406 (-7.05%) Direct
03/02/2026
03/04/2026
Sell
-1,717 @ $327.66
($562,585) 25,181 (-6.38%) Direct
02/13/2026
02/17/2026
Sell
-2,242 @ $310.08
($695,201) 24,848 (-8.28%) Direct
01/12/2026
01/14/2026
Sell
-1,510 @ $362.87
($547,929) 22,511 (-6.29%) Direct
10/03/2025
10b5-1
10/03/2025
Sell
-3,022 @ $451.48
($1,364,387) 20,221 (-13.00%) Direct
10/02/2025
10/03/2025
Sell
-2,937 @ $452.05
($1,327,675) 23,243 (-11.22%) Direct
08/19/2025
10b5-1
08/19/2025
Sell
-1,455 @ $458.41
($666,987) 20,221 (-6.71%) Direct
08/18/2025
08/19/2025
Sell
-1,396 @ $453.27
($632,759) 21,676 (-6.05%) Direct